Saving money is wise, but investing is profitable
In accordance with the legislation of the Czech Republic, the Company provides services only to qualified investors!

Prelude Therapeutics, Inc. Debut trading.

26.09.2020

In their debut trading on Friday, September 25 Prelude Therapeutics showed a 37.89 % raise and closed at $26.20 per share. Shortly before the company placed its shares in an IPO priced $19 per share.